GlassScriptPhysician profile
Sherwin Abdoli
NPI 1508386442
$6,658.32
in general payments reported to CMS, 2019-2025
13 companies · $2,255 in 2025
The $2,255 reported for 2025 was more than what 83% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $175 · 2020: $45.55 · 2022: $667 · 2023: $3,478 · 2024: $37.46 · 2025: $2,255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,500 · Food and Beverage: $1,271.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,500.00 |
| Food and Beverage | $1,270.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,586.17 | 2023-2025 | Davinci Xi, Da Vinci Surgical System |
| Medtronic, INC. | $1,031.97 | 2022-2025 | Ligasure, Signia, Interstim |
| Davol INC. | $400.00 | 2025 | Phasix Mesh |
| Integra Lifesciences Corporation | $229.54 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Merck Sharp & Dohme LLC | $114.60 | 2019 | |
| Tela Bio, INC. | $94.73 | 2022 | |
| Amgen INC. | $45.55 | 2020 | |
| Ethicon US, LLC | $41.72 | 2019-2024 | Echelon; Endopath |
| Cardiovascular Systems INC. | $36.23 | 2019 | |
| Baxter Healthcare | $24.21 | 2022 | |
| Smith+Nephew, INC. | $19.97 | 2024 | Pico 14 |
| Cook Medical LLC | $19.06 | 2023 | Advance |
| Daiichi Sankyo INC. | $14.57 | 2025 | Enhertu |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sherwin Abdoli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.